N/A(healthy adults)
Conditions
Sponsors
Morinaga & Co., Ltd.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1)Japanese women aged 30-59 years. 2)Individuals who are healthy without chronic physical illness, including skin diseases. 3)Individuals who are concerned about skin dryness. 4)Individuals whose written informed consent has been obtained. 5)Individulals who can visit an inspection facility and be inspected in designated days. 6)Individuals judged appropriate for the study by the principal.
Exclusion criteria
Exclusion criteria: 1) Individuals using medical products. 2) Individuals who have or are being treated for skin disease symptoms. 3) Individuals with wounds or inflammation at the skin measurement points. 4) Individuals with a history of serious liver, kidney, heart, lung, or blood disease. 5) Individuals with a history of serious gastrointestinal disease. 6) Individuals with alcoholism or a mental illness. 7) Individuals who used or applied medications for disease treatment in the past 1 month. 8) Individuals who may not control seasonal allergy symptoms with regular medications during the trial. 9) Individuals with food allergies. 10) Individuals with serious anemia. 11) Individuals who smoke. 12) Individuals who are or may be pregnant, or lactating. 13) Individuals whose lifestyle will change during the trial. 14) Individuals who will get sunburned during the trial. 15) Individuals who had a habit of ingesting foods for specified health uses or supplements containing ingredients of the test food in the past 3 months or will ingest them during the trial. 16) Individuals who had a habit of ingesting foods for specified health uses or supplements that improve skin condition in the past 3 months or will ingest them during the trial. 17) Individuals who had a habit of ingesting or applying pharmaceuticals, quasi-drugs, or cosmetics likely to affect the trial in the past 3 months. 18) Individuals who conducted hormone replacement therapy in the past 6 months. 19) Individuals who received special facial care at external institutions currently or within the past 6 months. 20) Individuals who received cosmetic medicine in the past 6 months. 21) Individuals who were hospitalized and received treatment in the past 6 months. 22) Individuals who participated in other clinical studies within one month of consent for this study or plan to participate in other clinical studies. 23) Individuals judged inappropriate for the study by the principal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Indexes for skin conditions (0, 8 weeks after ingestion) | — |
Countries
Japan
Contacts
Public ContactYosuke Seto
Morinaga & Co., Ltd. Health Science and Research Center, R&D institute
Outcome results
None listed